Recursion Pharmaceuticals, Inc. (RXRX)
3.185
-0.14
(-4.35%)
USD |
NASDAQ |
Nov 13, 16:00
3.16
-0.02
(-0.78%)
After-Hours: 19:59
Recursion Pharmaceuticals Price : 3.185 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 3.33 | 3.34 | 3.16 | 3.185 | 16.72M |
| Nov 12, 2026 | 3.435 | 3.46 | 3.265 | 3.33 | 20.57M |
| Nov 11, 2026 | 3.685 | 3.720 | 3.53 | 3.59 | 16.60M |
| Nov 10, 2026 | 3.69 | 3.77 | 3.47 | 3.55 | 19.10M |
| Nov 09, 2026 | 3.52 | 3.87 | 3.470 | 3.805 | 20.37M |
| Nov 06, 2026 | 3.585 | 3.645 | 3.48 | 3.52 | 15.59M |
| Nov 05, 2026 | 3.79 | 3.795 | 3.42 | 3.50 | 25.42M |
| Nov 04, 2026 | 3.83 | 4.01 | 3.72 | 3.88 | 20.59M |
| Nov 03, 2026 | 3.855 | 4.08 | 3.65 | 3.68 | 20.78M |
| Nov 02, 2026 | 4.11 | 4.17 | 3.78 | 3.83 | 22.57M |
| Oct 30, 2026 | 4.05 | 4.160 | 3.785 | 4.03 | 24.41M |
| Oct 29, 2026 | 4.25 | 4.515 | 4.15 | 4.24 | 20.96M |
| Oct 28, 2026 | 4.00 | 4.43 | 3.993 | 4.35 | 28.50M |
| Oct 27, 2026 | 3.81 | 4.145 | 3.730 | 4.05 | 22.17M |
| Oct 26, 2026 | 3.71 | 3.86 | 3.64 | 3.80 | 16.10M |
| Oct 23, 2026 | 3.52 | 3.70 | 3.45 | 3.70 | 19.08M |
| Oct 22, 2026 | 3.54 | 3.68 | 3.485 | 3.58 | 17.74M |
| Oct 21, 2026 | 3.66 | 3.76 | 3.56 | 3.64 | 19.36M |
| Oct 20, 2026 | 3.555 | 3.67 | 3.47 | 3.66 | 20.93M |
| Oct 19, 2026 | 3.53 | 3.69 | 3.48 | 3.61 | 30.01M |
| Oct 16, 2026 | 4.11 | 4.185 | 3.44 | 3.465 | 40.72M |
| Oct 15, 2026 | 3.65 | 4.41 | 3.53 | 4.16 | 62.87M |
| Oct 14, 2026 | 3.72 | 3.91 | 3.66 | 3.74 | 18.78M |
| Oct 13, 2026 | 4.01 | 4.05 | 3.82 | 3.835 | 19.76M |
| Oct 12, 2026 | 4.31 | 4.365 | 3.91 | 4.01 | 23.79M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Absci Corp. | 8.45 |
| Editas Medicine, Inc. | 2.17 |
| Twist Bioscience Corp. | 111.60 |
| Beam Therapeutics, Inc. | 22.83 |
| AbbVie, Inc. | 295.03 |
Price Related Metrics
| PS Ratio | 24.87 |
| Price to Book Value | 1.973 |
| Earnings Yield | -28.02% |
| Market Cap | 1.787B |